Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Welsch, Jo Anne
and
Granoff, Dan
2007.
Immunity to
Neisseria meningitidis
Group B in Adults despite Lack of Serum Bactericidal Antibody
.
Clinical and Vaccine Immunology,
Vol. 14,
Issue. 12,
p.
1596.
Trotter, Caroline
Findlow, Jamie
Balmer, Paul
Holland, Ann
Barchha, Rita
Hamer, Nick
Andrews, Nick
Miller, Elizabeth
and
Borrow, Ray
2007.
Seroprevalence of Bactericidal and Anti-Outer Membrane Vesicle Antibodies to
Neisseria meningitidis
Group B in England
.
Clinical and Vaccine Immunology,
Vol. 14,
Issue. 7,
p.
863.
Esposito, Susanna
Corbellini, Barbara
Bosis, Samantha
Pugni, Lorenza
Tremolati, Elena
Tagliabue, Claudia
Toneatto, Daniela
Mosca, Fabio
and
Principi, Nicola
2007.
Immunogenicity, safety and tolerability of meningococcal C CRM197 conjugate vaccine administered 3, 5 and 11 months post-natally to pre- and full-term infants.
Vaccine,
Vol. 25,
Issue. 26,
p.
4889.
Navarro-Alonso, José Antonio
2008.
Vacunas antimeningocócicas.
Enfermedades Infecciosas y Microbiología Clínica,
Vol. 26,
Issue. ,
p.
20.
Trotter, Caroline L.
McVernon, Jodie
Ramsay, Mary E.
Whitney, Cynthia G.
Mulholland, E. Kim
Goldblatt, David
Hombach, Joachim
and
Kieny, Marie-Paule
2008.
Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae.
Vaccine,
Vol. 26,
Issue. 35,
p.
4434.
Beernink, Peter T.
and
Granoff, Dan M.
2008.
Bactericidal Antibody Responses Induced by Meningococcal Recombinant Chimeric Factor H-Binding Protein Vaccines.
Infection and Immunity,
Vol. 76,
Issue. 6,
p.
2568.
Trotter, Caroline L
and
Maiden, Martin CJ
2009.
Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs.
Expert Review of Vaccines,
Vol. 8,
Issue. 7,
p.
851.
RACHAEL, T.
SCHUBERT, K.
HELLENBRAND, W.
KRAUSE, G.
and
STUART, J. M.
2009.
Risk of transmitting meningococcal infection by transient contact on aircraft and other transport.
Epidemiology and Infection,
Vol. 137,
Issue. 8,
p.
1057.
Read, Robert C.
Teare, Dawn M.
Pridmore, Alison C.
Naylor, Simone C.
Timms, James M.
Kaczmarski, Edward B.
Borrow, Raymond
and
Wilson, Anthony G.
2009.
The tumor necrosis factor polymorphism TNF (−308) is associated with susceptibility to meningococcal sepsis, but not with lethality*.
Critical Care Medicine,
Vol. 37,
Issue. 4,
p.
1237.
Snedecor, Sonya J.
Strutton, David R.
Ciuryla, Vincent
Schwartz, Elissa J.
and
Botteman, Marc F.
2009.
Transmission-dynamic model to capture the indirect effects of infant vaccination with Prevnar (7-valent pneumococcal conjugate vaccine (PCV7)) in older populations.
Vaccine,
Vol. 27,
Issue. 34,
p.
4694.
Foster, Rachel A.
Carlring, Jennifer
McKendrick, Michael W.
Lees, Andrew
Borrow, Ray
Read, Robert C.
and
Heath, Andrew W.
2009.
Evidence of a Functional B-Cell Immunodeficiency in Adults Who Experience Serogroup C Meningococcal Disease.
Clinical and Vaccine Immunology,
Vol. 16,
Issue. 5,
p.
692.
Horton, R.E.
Vidarsson, G.
Virji, M.
Williams, N.A.
and
Heyderman, R.S.
2009.
IgA1 antibodies specific for outer membrane protein PorA modulate the interaction between Neisseria meningitidis and the epithelium.
Microbial Pathogenesis,
Vol. 46,
Issue. 5,
p.
253.
Holst, Johan
Martin, Diana
Arnold, Richard
Huergo, Concepcion Campa
Oster, Philipp
O’Hallahan, Jane
and
Rosenqvist, Einar
2009.
Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis.
Vaccine,
Vol. 27,
Issue. ,
p.
B3.
Granoff, Dan M.
Welsch, Jo Anne
and
Ram, Sanjay
2009.
Binding of Complement Factor H (fH) to
Neisseria meningitidis
Is Specific for Human fH and Inhibits Complement Activation by Rat and Rabbit Sera
.
Infection and Immunity,
Vol. 77,
Issue. 2,
p.
764.
Biebl, Ariane
Muendlein, Axel
Kazakbaeva, Zhyrgal
Heuberger, Sigrid
Sonderegger, Gudrun
Drexel, Heinz
Lau, Susanne
Nickel, Renate
Kabesch, Michael
Simma, Burkhard
and
Hartl, Dominik
2009.
CD14 C-159T and Toll-Like Receptor 4 Asp299Gly Polymorphisms in Surviving Meningococcal Disease Patients.
PLoS ONE,
Vol. 4,
Issue. 10,
p.
e7374.
Roberts, Jonathan
Greenwood, Brian
and
Stuart, James
2009.
Sampling methods to detect carriage of Neisseria meningitidis; literature review.
Journal of Infection,
Vol. 58,
Issue. 2,
p.
103.
Al‐Tawfiq, Jaffar A.
Clark, Thomas A.
and
Memish, Ziad A.
2010.
Meningococcal Disease: The Organism, Clinical Presentation, and Worldwide Epidemiology.
Journal of Travel Medicine,
Vol. 17,
Issue. suppl 1,
p.
3.
Deasy, Alice
and
Read, Robert C
2010.
Genetic variation in pro-inflammatory cytokines and meningococcal sepsis.
Current Opinion in Infectious Diseases,
Vol. 23,
Issue. 3,
p.
255.
Campbell, Helen
Andrews, Nick
Borrow, Ray
Trotter, Caroline
and
Miller, Elizabeth
2010.
Updated Postlicensure Surveillance of the Meningococcal C Conjugate Vaccine in England and Wales: Effectiveness, Validation of Serological Correlates of Protection, and Modeling Predictions of the Duration of Herd Immunity.
Clinical and Vaccine Immunology,
Vol. 17,
Issue. 5,
p.
840.
Cortés, Juan-C.
Sánchez-Sánchez, Almudena
Santonja, Francisco-J.
and
Villanueva, Rafael-J.
2011.
epiModel: A system to build automatically systems of differential equations of compartmental type-epidemiological models.
Computers in Biology and Medicine,
Vol. 41,
Issue. 11,
p.
999.